If they don't make it this week they will probably be pulled off the calendar altogether.
We haven't seen as many of those break through deals the past two weeks, and next week is going to be more of the same. But there's a lot more strength in the biotech market than the last two week's run on the sector would indicate.
We're having a science fiction week in investment banking land. They're throwing so much out it's confusing the market.
This next week will be very, very quiet. Not only are there very few deals, but these are deals that wouldn't do well in a strong market.
This week has more stars in it than we've seen in a long time. It looks like the market's back.